Piru Perampalam
Chief Scientific Officer & Co-founder
Copoly.ai
Toronto, Canada
CSO and co-founder of Copoly.ai, a Canadian AI biotech building OncoSage (blood-based early cancer detection), OfficeSage (sovereign GenAI for government), and BioSage (biopharma research platform). PhD biochemistry; ex-Roche & Genentech.
My organisation
About me
Piru Perampalam is the co-founder and Chief Scientific Officer of Copoly.ai, a Canadian-based AI biotech company developing OncoSage, a blood-based early cancer detection platform built on platelet signatures and proprietary AI models. OncoSage is designed to make early, pan-cancer screening accessible through a simple blood draw, with ongoing clinical validation in partnership with London Health Sciences Centre and active international collaborations.
Alongside OncoSage, Piru leads Copoly's two complementary lines of work: OfficeSage, a sovereign, Microsoft 365–integrated generative AI platform tailored for Canadian federal departments and regulated enterprises, and BioSage, an AI-powered bioinrofmatics research platform biopharma partners.